Contributions of Hippocampal Cellular Damage and NMDA Receptor Dysfunction to Behavioral Markers of Schizophrenia

References

• Abi-Saab W. M., ĎSousa D. C., Moghaddam B., Krystal J. H. The NMDA antagonist model for schizophrenia: Promises and pitfalls. Pharmacopsychiatry 1998; 31: 104–109
   PubMed Web of Science ®Google Scholar
• Bakshi V. P., Geyer M. A. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. Journal of Newoscience 1998; 18: 8394–8401
   PubMed Web of Science ®Google Scholar
• Banerjee S. P., Zuck L. G., Yablonski-Alter E., Lidsky T. I. Glutamate agonist activity: Implications for antipsychotic drug action and schizophrenia. Neuroreport 1995; 6: 2500–2504
   PubMed Web of Science ®Google Scholar
• Bardgett M. E., Jackson J. L., Taylor G. T., Csernansky J. G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: An animal model of schizophrenia. Behavioural Brain Research 1995; 70: 153–164
   PubMed Web of Science ®Google Scholar
• Bardgett M. E., Jackson J. L., Taylor G. T., Csernansky J. G. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology 1998; 133: 270–287
   Web of Science ®Google Scholar
• Bilder R. M., Bogerts B., Ashtari M., Wu H., Alvir J. M., Jody D., et al. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophrenia Research 1995; 17: 47–58
   PubMed Web of Science ®Google Scholar
• Braff D., Grillon C., Geyer M. A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 1992; 49: 206–215
   PubMed Web of Science ®Google Scholar
• Braff D., Stone C, Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978; 15: 339–343
   PubMed Web of Science ®Google Scholar
• Breier A., Buchanan R. W., Elkashef A., Munson R. C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex and caudate structures. Archives of General Psychiatry 1992; 49: 921–926
   PubMed Web of Science ®Google Scholar
• Conrad A. J., Scheibel A. B. Schizophrenia and the hippocampus: The embryoiogical hypothesis extended. Schizophrenia Bulletin 1987; 13: 577–587
   PubMed Web of Science ®Google Scholar
• Duncan P. M., Duncan N. C. Free operant and T-maze avoidance performance by septal and hippocampal damaged rats. Physiology and Behavior 1971; 7: 687–693
   PubMed Web of Science ®Google Scholar
• Faustman W. O., Bardgett M., Faull K. F., Pfefferman A., Csernansky J. G. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. Biological Psychiatry 1999; 45: 68–75
   PubMed Web of Science ®Google Scholar
• Gray N. S., Hemsley D. R., Gray J. A. Abolition of latent inhibition in acute but not chronic schizophrenics. Neurological Psychiatry and Brain Research 1992; 1: 83–89
   Web of Science ®Google Scholar
• Grillon C, Ameli R., Charney D. S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenia patients. Biological Psychiatry 1992; 32: 939–943
   PubMed Web of Science ®Google Scholar
• Harris E. W., Ganong A. H., Cotman C. W. Long-term potentiation in the hippocampus involves activation of the N-methyl-d-aspartate receptors. Brain Research 1984; 323: 132–137
   PubMed Web of Science ®Google Scholar
• Heresco-Levy U., Javitt D. C. The role of N-Methyl-D-Aspartate receptor mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. European Neuropsychopharmacology 1998; 8: 141–152
   PubMed Web of Science ®Google Scholar
• Ishimaru M. J., Toru M. The glutamate hypothesis of schizophrenia. CNS Drugs 1997; 7: 47–67
   Web of Science ®Google Scholar
• Judd L. L., McAdams L., Budnick B., Braff D. L. Sensory gating deficits in schizophrenia: New results. American Journal of Psychiatry 1992; 149: 488–493
   PubMed Web of Science ®Google Scholar
• Kline L., Dccena E., Hitzemann R., McCaughran J. Acoustic startle, prepulse inhibition, locomotion and latent inhibition in the neuroleptic-responsive (NR) and neuroleptic-nonresponsive (NNR) lines of mice. Psychopharmacology 1998; 139: 322–331
   PubMed Web of Science ®Google Scholar
• Kovelman J. A., Scheibel A. B. A neurohistological correlate of schizophrenia. Biological Psychiatry 1984; 19: 1601–1621
   PubMed Web of Science ®Google Scholar
• Mansbach R. S., Geyer M. A. Effects of phencyclidine and phencyclidine biologs on sensory gating in the rat. Neuropsychopharmacology 1989; 2: 299–308
   PubMed Web of Science ®Google Scholar
• Nelson M. D., Saykin A. J., Flashman L. A., Riordan H. J. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging. Archives of General Psychiatry 1998; 55: 433–440
   PubMed Web of Science ®Google Scholar
• Newcomer J. W., Farber N. B., Jcvtovic-Todorovic V., Selge G., Melson A. K., Hershey T., et al. Ketamine induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 1999; 20: 106–118
   PubMed Web of Science ®Google Scholar
• Port R. L., Sample J. A., Seybold K. A. Partial hippocampal pyramidal cell loss alters behavior in rats: Implications for an animal model of schizophrenia. Brain Research Bulletin 1991; 26: 993–996
   PubMed Web of Science ®Google Scholar
• Port R. L., Seybold K. S. Hippocampal synaptic plasticity as a biological substrate underlying episodic psychosis. Biological Psychiatry 1995; 37: 318–324
   PubMed Web of Science ®Google Scholar
• Robinson G. B., Port R. L., Stillwell E. J. Latent inhibition of the classically conditioned rabbit nictitating membrane response is unaffected by the NMDA antagonist MK.801. Psychobiohgy 1993; 21: 120–124
   Google Scholar
• Scheibel A. B., Kovelman J. A. Disorientation of hippocampal pyramidal cells and its processes in the schizophrenic patient. Biological Psychiatry 1981; 16: 101–102
   Web of Science ®Google Scholar
• Schmaltz L. W., Theios J. Acquisition and extinction of a classically conditioned response in hippocampectomized rabbits. Journal of Comparative and Physiological Psychology 1972; 79: 328–333
   PubMed Web of Science ®Google Scholar
• Solomon P. R., Moore J. W. Latent inhibition and stimulus generalization of the classically conditioned nictitating membrane response in rabbit following dorsal hippocampal ablation. Journal of Comparative and Physiological Psychology 1975; 89: 1192–1203
   PubMed Web of Science ®Google Scholar
• Tamminga C. A. Schizophrenia and glutamatergic transmission. Critical Reviews in Neurobiology 1998; 12: 21–36
   PubMed Web of Science ®Google Scholar
• van Berckel B. N. M., Evenblij C. N., van Loon B. J. A.M., Maas M. F., van der Geld M. A. M., Wynne H. J., et al. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind parallel placebo-controlled study. Neuropsychopharmacology 1999; 21: 203–210
   PubMed Web of Science ®Google Scholar
• Vinogradova O. S. Functional organization of the limbic system in the process of registration ofinformation: Facts and hypotheses. The hippocampus, R. L. Isaacson, K. H. Pribram. Plenum Press, New York 1975; 3–69
   Google Scholar
• Zihl J., Gron G., Brunnauer A. Cognitive deficits in schizophrenia and affective disorders: Evidence for a final common pathway disorder. Acta Psychiatrica Scandinavica 1998; 97: 351–357
   PubMed Web of Science ®Google Scholar